Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetic in Normal Population”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Early research (Phase 1)Study completedNCT01513083
What this trial is testing

Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

Who this might be right for
Breast Cancer
Hoffmann-La Roche 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04544189
What this trial is testing

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Novartis Pharmaceuticals 69
Very early researchNot Yet RecruitingNCT07373743
What this trial is testing

Pharmacokinetic (PK) Study of Tafenoquine in Healthy Adults

Who this might be right for
Pharmacokinetic in Normal Population
State University of New York - Upstate Medical University 20
Early research (Phase 1)Study completedNCT00750620
What this trial is testing

A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Astellas Pharma Inc 33
Early research (Phase 1)Looking for participantsNCT07258745
What this trial is testing

Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants

Who this might be right for
Psoriasis
Chong Kun Dang Pharmaceutical 213
Post-approval studies (Phase 4)Study completedNCT01167452
What this trial is testing

Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations

Who this might be right for
ObesityPharmacokineticsMRSA+2 more
Texas Tech University Health Sciences Center 36
Early research (Phase 1)Study completedNCT07347808
What this trial is testing

A Pharmacokinetic Study of VCT220 With Moderate Renal Impairment Patients

Who this might be right for
Obesity & Overweight
Vincentage Pharma Co., Ltd 16
Early research (Phase 1)Study completedNCT01439204
What this trial is testing

Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 223
Early research (Phase 1)Study completedNCT05724693
What this trial is testing

Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function

Who this might be right for
Healthy VolunteerHepatic Impairment
Atea Pharmaceuticals, Inc. 39
Early research (Phase 1)Study completedNCT06929039
What this trial is testing

Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis (RA
Kashiv BioSciences, LLC 300
Early research (Phase 1)Study completedNCT03040479
What this trial is testing

Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function

Who this might be right for
Migraine
Eli Lilly and Company 24
Early research (Phase 1)Study completedNCT01861509
What this trial is testing

BP-C1 in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast CancerStage IV Breast Cancer
Meabco A/S 10
Large-scale testing (Phase 3)Study completedNCT02142075
What this trial is testing

Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure

Who this might be right for
Renal FailureCritical CareGram Positive Bacteria
Poitiers University Hospital
Early research (Phase 1)Study completedNCT00275093
What this trial is testing

Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function

Who this might be right for
Hepatic ComplicationsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 130
Early research (Phase 1)Study completedNCT00650156
What this trial is testing

Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 24
Early research (Phase 1)Study completedNCT02599714
What this trial is testing

Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer

Who this might be right for
Advanced and Metastatic Breast Cancer
AstraZeneca 54
Early research (Phase 1)Study completedNCT04656795
What this trial is testing

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Who this might be right for
Renal ImpairmentNormal Renal Function
Tanabe Pharma America, Inc. 32
Post-approval studies (Phase 4)Study completedNCT01307930
What this trial is testing

Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations

Who this might be right for
ObesityMycoses
Texas Tech University Health Sciences Center 20
Early research (Phase 1)Study completedNCT03799848
What this trial is testing

A Single Dose Study of Oral Vadadustat in Subjects With Normal and Impaired Hepatic Function

Who this might be right for
Hepatic Impairment
Akebia Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT02805725
What this trial is testing

Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide

Who this might be right for
Soft-tissue Sarcomas
Institut Bergonié 50
Next Page